Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Secondary prevention of meningococcal disease.

× No keyword cloud information.

8 in total

1. Preventing secondary cases of meningococcal disease by identifying and eradicating disease-causing strains in close contacts of patients.

Authors: B E Kristiansen; Y Tveten; E Ask; T Reiten; A B Knapskog; J Steen-Johnsen; G Hopen
Journal: Scand J Infect Dis Date: 1992

2. Control of meningococcal disease.

Authors: D M Jones
Journal: BMJ Date: 1989-03-04

3. Bactericidal antibody after colonization with Neisseria meningitidis.

Authors: L B Reller; R R MacGregor; H N Beaty
Journal: J Infect Dis Date: 1973-01 Impact factor: 5.226

4. Use of arbitrarily primed polymerase chain reaction analysis to type disease and carrier strains of Neisseria meningitidis isolated during a university outbreak.

Authors: J P Woods; D Kersulyte; R W Tolan; C M Berg; D E Berg
Journal: J Infect Dis Date: 1994-06 Impact factor: 5.226

5. A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants.

Authors: P A Twumasi; S Kumah; A Leach; T J O'Dempsey; S J Ceesay; J Todd; C V Broome; G M Carlone; L B Pais; P K Holder
Journal: J Infect Dis Date: 1995-03 Impact factor: 5.226

6. PCR amplicon restriction endonuclease analysis of the chromosomal dhps gene of Neisseria meningitidis: a method for studying spread of the disease-causing strain in contacts of patients with meningococcal disease.

Authors: B E Kristiansen; C Fermér; A Jenkins; E Ask; G Swedberg; O Sköld
Journal: J Clin Microbiol Date: 1995-05 Impact factor: 5.948

7. Use of single-dose ofloxacin to eradicate tonsillopharyngeal carriage of Neisseria meningitidis.

Authors: O H Gilja; A Halstensen; A Digranes; H Mylvaganam; A Aksnes; E A Høiby
Journal: Antimicrob Agents Chemother Date: 1993-09 Impact factor: 5.191

8. Reversal of developmental delays in iron-deficient anaemic infants treated with iron.

Authors: P Idjradinata; E Pollitt
Journal: Lancet Date: 1993-01-02 Impact factor: 79.321

8 in total

10 in total

1. Meningococcal disease in healthcare workers. Vaccine is available in Latin America.

Authors: C Trujillo
Journal: BMJ Date: 2000-01-22

Review 2. Recognition, treatment and complications of meningococcal disease.

Authors: F A Riordan; A P Thomson
Journal: Paediatr Drugs Date: 1999 Oct-Dec Impact factor: 3.022

3. Secondary prevention of meningococcal disease. No evidence exists to support use of penicillin.

Authors: T Stokes; R Shukla; P Monk
Journal: BMJ Date: 1996-06-15

4. Secondary prevention of meningococcal disease. Ceftriaxone or ciprofloxacin should be considered as first line prophylaxis.

Authors: M J Martin; N A Hutchinson; I J Eltringham; P Y Lee; K Birthistle
Journal: BMJ Date: 1996-06-15

Secondary prevention of meningococcal disease.

1. Preventing secondary cases of meningococcal disease by identifying and eradicating disease-causing strains in close contacts of patients.

2. Control of meningococcal disease.

3. Bactericidal antibody after colonization with Neisseria meningitidis.

4. Use of arbitrarily primed polymerase chain reaction analysis to type disease and carrier strains of Neisseria meningitidis isolated during a university outbreak.

5. A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants.

6. PCR amplicon restriction endonuclease analysis of the chromosomal dhps gene of Neisseria meningitidis: a method for studying spread of the disease-causing strain in contacts of patients with meningococcal disease.

7. Use of single-dose ofloxacin to eradicate tonsillopharyngeal carriage of Neisseria meningitidis.

8. Reversal of developmental delays in iron-deficient anaemic infants treated with iron.

1. Meningococcal disease in healthcare workers. Vaccine is available in Latin America.

Review 2. Recognition, treatment and complications of meningococcal disease.

3. Secondary prevention of meningococcal disease. No evidence exists to support use of penicillin.

4. Secondary prevention of meningococcal disease. Ceftriaxone or ciprofloxacin should be considered as first line prophylaxis.

5. Secondary prevention of meningococcal disease. Penicillin is not recommended in British guidelines.

6. Secondary prevention of meningococcal disease. Cases are "unavoidably unpredictable".

7. Secondary prevention of meningococcal disease. British guidelines should have been considered.

8. Preventative strategies on meningococcal disease.

Review 9. Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Review 10. Recognizing meningococcal disease: the case for further research in primary care.